Thompson Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Sell
20
-5
-20% -$5.11K ﹤0.01% 361
2026
Q1
$23K Sell
25
-7
-22% -$7.1K ﹤0.01% 356
2025
Q4
$34.4K Hold
32
﹤0.01% 320
2025
Q3
$24.4K Buy
32
+7
+28% +$5.21K ﹤0.01% 354
2025
Q2
$19.5K Hold
25
﹤0.01% 371
2025
Q1
$20.6K Hold
25
﹤0.01% 353
2024
Q4
$19.3K Hold
25
﹤0.01% 362
2024
Q3
$22.1K Hold
25
﹤0.01% 329
2024
Q2
$22.6K Hold
25
﹤0.01% 324
2024
Q1
$19.4K Sell
25
-25
-50% -$17.8K ﹤0.01% 354
2023
Q4
$29.1K Hold
50
﹤0.01% 269
2023
Q3
$26.9K Buy
+50
New +$25.8K ﹤0.01% 271

Other funds holding LLY

Thompson Investment Management's LLY Position: Q2 2026 in Review

Thompson Investment Management reduced its Eli Lilly (LLY) stake by 20% in Q2 2026, selling an estimated $5.11K and leaving 20 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Thompson Investment Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $34.4K in Q4 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Thompson Investment Management held 20 shares of Eli Lilly worth $24K as of Q2 2026.
  • Thompson Investment Management sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up ﹤0.01% of Thompson Investment Management's portfolio in Q2 2026, its #361 holding.
  • Thompson Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Thompson Investment Management's Eli Lilly position peaked at $34.4K in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.